Sinotau Pharmaceutical Group

Works in Cardiovascular · Neurology · Oncology · Psychiatry · Renal & urogenital

Sinotau Pharmaceutical Group is a clinical trial sponsor. It has 6 active clinical trials with 1,076 planned participants, across 5 therapeutic areas. Since 2021 it has completed 8 trials and stopped 1 early.

Trial track record · since 2021

6Active trials1,076 planned participants
8Completed0 with results posted
1Stopped early11% of finished trials

Pipeline · 6 active trials

StageTrialStatus

Questions about Sinotau Pharmaceutical Group

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Sinotau Pharmaceutical Group.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.